Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
6
×
indiana blog main
indiana top stories
life sciences
medicare
6
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
novartis
biogen
deals
merck
amgen
cancer
cancer immunotherapy
celgene
clinical trials
crispr
eli lilly
What
bio
roundup
6
×
companies
crispr
drug
ipo
life
new
patients
remains
science
talk
terms
acquisitions
albert
allogene
alzheimer’s
approval
arena’s
becker
biggest
billions
biogen’s
biopharmaceutical
bounty
bourla
cancer
ceo
cig
comeback
company
congress
convo
corner
deals
delivered
democrats
diversity
divided
dollars
Language
unknown
Current search:
medicare
×
roundup
×
" gene therapy "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More